For the chemical carcinoma model, we used our previously established Panx3 KO mouse model (Moon et al., 2015) to assess the potential role of PANX3 in cSCC carcinogenesis because currently there are no commercially available PANX3‐specific channel blockers. Here, PANX3 is linked to carcinoma.